KOLINPHARMA
I prodotti Kolinpharma
News
From Kolinpharma world
19/11/2021
KOLINPHARMA® “Growth Leader 2022” for the fourth consecutive year

The company is confirmed as one of the 450 Italian companies that recorded the highest turnover growth rates between 2017 and 2020, marking, in the observation period, a turnover CAGR of 26.39%.

"Growth Leader 2022" is the recognition now in its third edition born from the collaboration between Il Sole 24 Ore and Statista, world leader in statistical analysis and market research.

The study concerned the analysis of approximately 8,000 companies based in Italy, with a turnover exceeding Euro 100 thousand in 2017 and exceeding Euro 1.5 million in 2020, which stood out in the three-year period 2017-2020 for high turnover growth rates, in terms of CAGR, achieved mainly at the organic level.

The complete ranking is available online.

 


< Back
Ultime news
Kolinpharma® launches KIPFeR® following agreement with Nemysis LTD
10/01/2024
Kolinpharma® launches KIPFeR® following agreement with Nemysis LTD
Kolinpharma® is pleased to announce the launch of KIPFeR®
09/01/2024
Kolinpharma® is pleased to announce the launch of KIPFeR®
“Science accuracy and listen to people”
“Science accuracy and listen to people”